G. Khambatta

发表

A Cereblon Modulator (CC-220) with Improved Degradation of Ikaros and Aiolos.

Chin-Chun Lu, Y. Satoh, L. LeBrun, 2017, Journal of medicinal chemistry.

Perioperative lymphocyte adenylyl cyclase function in the pediatric cardiac surgical patient.

R. Smiley, J. Quaegebeur, C. Pantuck, 1996, Critical care medicine.

Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115.

P. Worland, D. Mortensen, B. Cathers, 2015, Journal of medicinal chemistry.

CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization

P. Worland, Shuichan Xu, D. Mortensen, 2015, Molecular Cancer Therapeutics.

Characterization and kinetic mechanism of catalytic domain of human vascular endothelial growth factor receptor-2 tyrosine kinase (VEGFR2 TK), a key enzyme in angiogenesis.

B. Mroczkowski, K. Appelt, C. Pinko, 1998, Biochemistry.

Discovery of the c-Jun N-Terminal Kinase Inhibitor CC-90001.

Y. Satoh, B. Bennett, D. Mortensen, 2021, Journal of medicinal chemistry.

Discovery of mammalian target of rapamycin (mTOR) kinase inhibitor CC-223.

P. Worland, D. Mortensen, B. Cathers, 2015, Journal of medicinal chemistry.

Discovery of the Selective Protein Kinase C-θ Kinase Inhibitor, CC-90005.

E. Hur, Lisa Morrison, B. Bennett, 2021, Journal of medicinal chemistry.

Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115.

P. Worland, D. Mortensen, B. Cathers, 2015, Journal of medicinal chemistry.

CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and In Vivo Characterization

P. Worland, Shuichan Xu, D. Mortensen, 2015, Molecular Cancer Therapeutics.